Hensen, Marja; Heeg, Bart; Lothgren, Mickael Lthgren; … - In: Applied Health Economics and Health Policy 8 (2010) 5, pp. 327-341
Background: In Sweden, risperidone long-acting injectable (RLAI) is generally used in a population of schizophrenia … schizophrenia population. Objectives: To analyse the clinical and economic effects of RLAI in the Swedish treatment practice using a …-compliant patient population and the general schizophrenia population. Methods: An existing DES model was adapted to simulate the …